Steroid lipomatosis

Summary

Steroid lipomatosis (MONDO:0006612) is a disease. A subtype of lipomatosis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	steroid lipomatosis
Mondo ID	MONDO:0006612
DOID	DOID:3925
NCIT	C27487
UMLS	C1336506
MedGen	234364
Is cancer (heuristic)	no

Also known as: steroid lipomatosis

Disease family

Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorder › musculoskeletal system benign neoplasm › benign connective and soft tissue neoplasm › benign lipomatous neoplasm › lipomatosis › steroid lipomatosis

Related subtypes (8): diffuse lipomatosis, mediastinal lipomatosis, pelvic lipomatosis, adiposis dolorosa, multiple symmetric lipomatosis, encephalocraniocutaneous lipomatosis, congenital infiltrating lipomatosis of the face, pancreatic lipomatosis duodenal stenosis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.